Home›Stock Screener›Vaxfab Enterprises›Financial Statements

Vaxfab Enterprises Complete Financial Statements

5 Years of Data
2026 - 2022

In FY2026, Vaxfab Enterprises (VEL) reported revenue ₹61 Cr, net profit ₹2 Cr and EPS ₹0.26, with a net profit margin of 3.3% and ROE of 4.5%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Examine VEL earnings for recent quarterly revenue, profit and EPS trends.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 3.28% 2026 data
EBITDA Margin 13.11% 2026 data
Operating Margin -15.00% 2026 data
Return on Assets 0.98% 2026 data
Return on Equity 4.55% 2026 data

Balance Sheet Ratios

Current Ratio 168.00 2026 data
Equity Ratio 21.57% 2026 data
Asset Turnover 0.30 2026 data

VEL Revenue, Net Profit & EBITDA — Year-on-Year Growth

VEL YoY (Mar 2025 vs Mar 2026) — revenue +17.3%, net profit -50.0%, EBITDA +60.0%, expenses +12.8%. For live price, earnings ratios and company overview, see VEL stock price BSE.

Revenue Growth
+17.3%
Year-over-Year
Net Profit Growth
-50.0%
Year-over-Year
EBITDA Growth
+60.0%
Year-over-Year
Expense Growth
+12.8%
Year-over-Year
Assets Growth
+655.6%
Year-over-Year
Equity Growth
+158.8%
Year-over-Year

VEL Income Statement — Revenue, EBITDA & Net Profit

Vaxfab Enterprises revenue ₹61 Cr, EBITDA ₹8 Cr, net profit ₹2 Cr, EPS ₹0.26 (2026) — net profit margin 3.3%. Analyse VEL shareholder distribution to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Dec 2024 Mar 2023 Jun 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022
Revenue 61 52 52 12 12 46 14 4 0 0 0 2
Expenses 53 54 47 14 15 39 14 4 0 0 0 2
EBITDA 8 -3 5 -1 -3 7 0 0 0 0 0 0
Operating Profit Margin % -15.00% 1.00% 8.00% 7.00% 2.00% 14.00% 2.00% 6.00% -12.00% 33.00% 31.00% 7.00%
Depreciation 4 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 4 -3 5 -1 -3 6 0 0 0 0 0 0
Tax 2 -1 1 0 0 0 0 0 0 0 0 0
Net Profit 2 -2 4 -1 -3 6 0 0 0 0 0 0
Earnings Per Share (₹) 0.26 -0.27 0.48 0.00 -0.39 0.76 0.33 0.31 0.01 0.88 0.02 0.85

VEL Balance Sheet — Assets, Liabilities & Shareholders' Equity

VEL total assets ₹204 Cr, total equity ₹44 Cr, total liabilities ₹ Cr (2026) — ROE 4.5%.

Years Annual Data ₹ Crores
Particulars 2026 2023 2022
ASSETS
Total Assets 204 27 3
Current Assets 168 14 2
Fixed Assets 0 0 0
Capital Work in Progress 0 0 0
Investments 7 12 0
Other Assets 0 14 3
LIABILITIES
Total Liabilities
Current Liabilities 1 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 44 17 3
Share Capital 40 9 2
Reserves & Surplus 4 8 2

VEL Cash Flow Statement — Operating, Investing & Financing

Vaxfab Enterprises operating cash flow ₹2 Cr, investing ₹-12 Cr, financing ₹14 Cr, net cash flow ₹4 Cr (2023).

Periods ₹ Crores
Particulars March 2023 March 2022
Operating Activities 2 0
Investing Activities -12 0
Financing Activities 14 0
Net Cash Flow 4 0